Suppr超能文献

口服耐受通过调节免疫微环境抑制小鼠特应性皮炎样 2 型炎症。

Oral tolerance inhibits atopic dermatitis-like type 2 inflammation in mice by modulating immune microenvironments.

机构信息

Department of Dermatology, Gachon University Gil Medical Center, Incheon, Republic of Korea.

Department of Microbiology, School of Medicine, Gachon University, Incheon, Republic of Korea.

出版信息

Allergy. 2017 Mar;72(3):397-406. doi: 10.1111/all.12960. Epub 2016 Jul 22.

Abstract

BACKGROUND

Oral tolerance is immune unresponsiveness induced by oral administration of innocuous antigens. Oral administration of allergens has been shown to be effective for suppressing IgE production in allergic responses. However, whether oral tolerance has a role in protection from allergic skin inflammation has not been fully investigated. Here, we evaluated the potential protective role of oral tolerance in a murine model of atopic dermatitis (AD) and investigated the underlying immunologic mechanisms.

METHODS

Mice were fed with ovalbumin (OVA) in drinking water then epicutaneously sensitized by repeated application of OVA to tape-stripped skin. Skin biopsies were analyzed for immunohistopathologic features. Levels of antibodies in sera and intestinal washes were measured by ELISA. Flow cytometry and real-time PCR analysis of the skin and mesenteric lymph nodes (MLN) were performed to investigate the immunologic effects of oral tolerance in epicutaneous (EC) sensitization-induced allergic responses.

RESULTS

Induction of oral tolerance effectively inhibited inflammatory responses provoked by EC sensitization. Tolerogenic immune mediators were significantly increased in the skin and MLN of EC-sensitized mice following induction of oral tolerance. A marked increase in Il5 and Il13 expression and infiltration of eosinophils and type 2 innate lymphoid cells (ILC2) in the skin of EC-sensitized mice were significantly inhibited by oral tolerance.

CONCLUSIONS

Oral tolerance plays a protective role in the development of AD in a murine model by modulating immune microenvironments to be more favorable for immune regulation. This modulation involves inhibition of ILC2 infiltration in skin lesions.

摘要

背景

口服给予无害抗原可诱导口服耐受,即免疫无应答。口服给予变应原已被证明可有效抑制过敏反应中 IgE 的产生。然而,口服耐受在预防过敏皮肤炎症中的作用尚未得到充分研究。在这里,我们评估了口服耐受在特应性皮炎(AD)小鼠模型中的潜在保护作用,并研究了其潜在的免疫机制。

方法

通过在饮用水中给予卵清蛋白(OVA)并用 OVA 反复贴皮致敏来致敏小鼠。分析皮肤活检的免疫组织病理学特征。通过 ELISA 测量血清和肠灌洗液中的抗体水平。通过流式细胞术和实时 PCR 分析皮肤和肠系膜淋巴结(MLN),研究口服耐受对经皮(EC)致敏诱导的过敏反应的免疫效应。

结果

口服耐受的诱导可有效抑制 EC 致敏引起的炎症反应。在诱导口服耐受后,EC 致敏小鼠的皮肤和 MLN 中显著增加了耐受诱导的免疫调节介质。EC 致敏小鼠皮肤中 Il5 和 Il13 的表达以及嗜酸性粒细胞和 2 型先天淋巴细胞(ILC2)的浸润显著增加,口服耐受可显著抑制这些变化。

结论

口服耐受通过调节免疫微环境以更有利于免疫调节,在 AD 小鼠模型中发挥保护作用。这种调节涉及抑制皮肤病变中 ILC2 的浸润。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验